Jae-Su Shin

Title: The Innovations of Jae-Su Shin

Introduction

Jae-Su Shin is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds that can aid in cancer treatment. His work focuses on the inhibition of microtubule formation, which is crucial in the proliferation of malignant tumors.

Latest Patents

Jae-Su Shin holds a patent for benzophenone derivatives that are useful for inhibiting the formation of microtubules. The patent discloses novel benzophenone derivatives represented by a specific formula, along with their pharmaceutically acceptable salts, hydrates, or solvates. These compounds are part of a pharmacological composition that can be used as therapeutic drugs. The benzophenone derivatives exhibit inhibition activity of microtubule formation and can effectively treat the normal proliferative state of malignant tumors by targeting and killing actively proliferating cells.

Career Highlights

Jae-Su Shin is currently associated with Chong Kun Dang Pharmaceutical Corporation, where he continues to innovate and develop new therapeutic solutions. His expertise in pharmacology and drug development has positioned him as a valuable asset in the pharmaceutical industry.

Collaborations

Some of his notable coworkers include Young-Min Kwon and Sun-Ju Kong, who contribute to the collaborative efforts in research and development within the company.

Conclusion

Jae-Su Shin's work in developing benzophenone derivatives showcases his commitment to advancing cancer treatment through innovative pharmaceutical solutions. His contributions are vital in the ongoing fight against malignant tumors, and his patent reflects the potential for significant therapeutic advancements.